EUVIMEDOdkrijte EUVIMED
Crossref

Chronic Gallic Acid Treatment Attenuates Hippocampal Neurodegeneration in Aged Rats

Sonia Irais Gonzalez-Cano, Daniel Juarez-Serrano, Anabella Handal, José Luis Morán Perales, Rubén A Vázquez-Roque iD, Fabián Galindo-Ramírez, Samuel Treviño iD, Jorge Guevara iD, Alfonso Díaz iD

Synapse · 2026

DOI: 10.1002/syn.70036 ↗

At a glance

Journal article in Synapse, 2026. Written by Sonia Irais Gonzalez-Cano and 8 co-authors. Institution: Institute of Physiology, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico. Major MEDLINE topics: Gallic Acid, Hippocampus, Aging, Neuroprotective Agents. 58 references. Funded by: VIEP-BUAP, PAPIIT-UNAM, Vicerrectoría de Investigación y Estudios de Posgrado, Benemérita Universidad Autónoma de Puebla.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

In recent years, global life expectancy has risen significantly, leading to a marked increase in the elderly population. Aging disproportionately affects the brain, resulting in cognitive decline and increased susceptibility to neurodegenerative diseases. This vulnerability is largely due to the high metabolic activity of neural tissue and its sensitivity to reactive oxygen species (ROS). Consequently, oxidative and inflammatory processes are key contributors to cellular damage and age‐related cognitive deficits. These oxidative processes may act as primary drivers of neuronal damage during aging. Recent evidence suggests that phenolic compounds may play a crucial role in neuroprotective strategies. Among these, gallic acid (GA) has garnered attention due to its potent antioxidant and anti‐inflammatory properties, which enhance neuronal resilience in animal models. However, the effects of GA on hippocampal neurodegeneration during aging remain unclear. In this study, we evaluated the impact of GA on learning, memory, redox balance, neuroinflammation, apoptosis, and synaptic plasticity in the hippocampus (Hp) of aged rats. Male rats aged 18 months received a daily dose of GA (20 mg/kg) for 60 days. GA treatment significantly improved short‐ and long‐term recognition memory. In the Hp, ROS, tumor necrosis factor‐alpha (TNF‐α), interleukin‐1 beta (IL‐1β), and lipid peroxidation were reduced, while superoxide dismutase (SOD) and catalase (CAT) activities increased. GA administration also decreased caspase‐3 expression. Collectively, these findings indicate that GA enhances antioxidant and anti‐inflammatory defenses, thereby mitigating hippocampal damage and supporting its potential as a promising therapeutic strategy to prevent or reduce neurodegenerative disorders associated with aging.

Subjects

MeSH terms (MEDLINE)

Gallic AcidHippocampusAgingNeuroprotective AgentsNeurodegenerative DiseasesAnimalsMaleRatsNeuronal PlasticityApoptosisOxidative StressReactive Oxygen SpeciesAntioxidantsRats, Wistar

Author keywords

brain agingneuroinflammationneuroplasticityoxidative stresspolyphenolsrecognition memory

Substances

Gallic AcidNeuroprotective AgentsReactive Oxygen SpeciesAntioxidants

Authors and institutions

  • Institute of Physiology, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
  • Faculty of Chemical Sciences, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
  • Department of Reproductive Biology and Toxicology, Institute of Sciences, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
  • Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

ORCID profiles: Rubén A Vázquez-Roque, Samuel Treviño, Jorge Guevara, Alfonso Díaz

Funding

  • VIEP-BUAP
  • PAPIIT-UNAM
  • Vicerrectoría de Investigación y Estudios de Posgrado, Benemérita Universidad Autónoma de Puebla
  • Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica

Cite

APA

Gonzalez-Cano, S. I., Juarez-Serrano, D., Handal, A., Morán Perales, J. L., Vázquez-Roque, R. A., Galindo-Ramírez, F., Treviño, S., Guevara, J., & Díaz, A. (2026). Chronic Gallic Acid Treatment Attenuates Hippocampal Neurodegeneration in Aged Rats. Synapse. https://doi.org/10.1002/syn.70036

Vancouver

Gonzalez-Cano SI, Juarez-Serrano D, Handal A, Morán Perales JL, Vázquez-Roque RA, Galindo-Ramírez F, et al. Chronic Gallic Acid Treatment Attenuates Hippocampal Neurodegeneration in Aged Rats. Synapse. 2026. doi:10.1002/syn.70036

BibTeX
@article{GonzalezCano2026,
  author = {Gonzalez-Cano, Sonia Irais and Juarez-Serrano, Daniel and Handal, Anabella and Morán Perales, José Luis and Vázquez-Roque, Rubén A and Galindo-Ramírez, Fabián and Treviño, Samuel and Guevara, Jorge and Díaz, Alfonso},
  title = {Chronic Gallic Acid Treatment Attenuates Hippocampal Neurodegeneration in Aged Rats},
  journal = {Synapse},
  year = {2026},
  doi = {10.1002/syn.70036}
}
Start for free →